Publication | Closed Access
Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway
57
Citations
12
References
2020
Year
ObesityMetabolic SyndromeInflammationSestrin2-mediated Nrf2/ho-1 PathwayMetabolic DisorderMedicineLiver PhysiologyPhysiologyMetabolic RegulationFatty Liver DiseaseMetabolismPharmacologyDrug-induced Liver InjuryOxidative StressHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1